Temtamy–Shalash syndrome
Temtamy–Shalash syndrome is a rare genetic disorder characterized by a range of physical and developmental anomalies. First identified by Temtamy and Shalash in 1969, this syndrome has since been a subject of interest in the field of genetics and pediatrics. The syndrome is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Symptoms and Characteristics
The hallmark features of Temtamy–Shalash syndrome include intellectual disability, growth retardation, and distinctive facial features. These facial features often encompass a broad nose, deep-set eyes, and a prominent forehead. Other physical anomalies associated with the syndrome may include brachydactyly (shortening of the fingers and toes), syndactyly (fusion of the fingers or toes), and various skeletal abnormalities.
Genetics
The genetic basis of Temtamy–Shalash syndrome involves mutations in a specific gene, although the exact gene associated with the syndrome has not been conclusively identified. The disorder follows an autosomal recessive pattern of inheritance. This means that for a child to be affected by the syndrome, they must inherit one mutated gene from each parent. Parents of an affected child are typically carriers of the syndrome but do not show symptoms themselves.
Diagnosis
Diagnosis of Temtamy–Shalash syndrome is primarily based on the clinical presentation and physical findings. Genetic testing may be utilized to confirm the diagnosis, especially in cases where the clinical presentation is ambiguous. Early diagnosis is crucial for the management of the syndrome and to provide appropriate genetic counseling to the affected families.
Management and Treatment
There is no cure for Temtamy–Shalash syndrome, and treatment is symptomatic and supportive. Management strategies may include physical therapy, special education programs, and other interventions aimed at improving the quality of life of affected individuals. Surgical interventions may be necessary to correct certain physical anomalies such as syndactyly.
Prognosis
The prognosis for individuals with Temtamy–Shalash syndrome varies depending on the severity of the symptoms and the presence of associated complications. With appropriate management and supportive care, individuals with the syndrome can lead a relatively normal life.
Research
Research on Temtamy–Shalash syndrome is ongoing, with studies focusing on identifying the genetic mutations responsible for the syndrome and understanding the mechanism of disease. Advances in genetic research may offer new insights into the syndrome and potential therapeutic targets in the future.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD